QA: Tonix Pharmaceuticals Holding Corp in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001430306_2022_Tonix_Pharmaceuticals_Holding_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp

  xvar xval
0 AssetsCurrent 189,049,000
1 IntangibleAssetsNetIncludingGoodwill 120,000
2 PropertyPlantAndEquipmentNet 50,558,000
3 remainder_Assets 1,173,000
4 LiabilitiesCurrent 21,716,000
5 LiabilitiesNoncurrent 467,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 43,394,832
9 ResearchAndDevelopmentExpense 140,321,706
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 13,160
13 remainder_ComprehensiveNetIncome -24,989
  yvar yval
0 Assets 240,900,000
1 Liabilities 22,183,000
2 Expenses 183,716,538
3 Revenues 0
4 StockholdersEquity 218,717,000
5 NetIncome -183,703,378
6 ComprehensiveNetIncome -183,715,872
7 BaseVar 223,418,844
8 EconomicCapitalRatiobeforeLimitedLiability 2.23
9 EconomicCapitalRatio 3.18

Edgar->Model Mapping

Feature Distribution

Change over Time